questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Autoanticorps
Autoanticorps : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Autoanticorps
Tests de laboratoire
Anticorps antinucléaires
Autoanticorps
Maladies auto-immunes
Autoanticorps
Autoanticorps
Asymptomatique
Symptômes
5
Douleurs articulaires
Polyarthrite rhumatoïde
Troubles neurologiques
Sclérose en plaques
Éruptions cutanées
Lupus érythémateux
Organes internes
Maladies auto-immunes
Prévention
5
Prévention
Mode de vie sain
Vaccinations
Autoanticorps
Stress
Maladies auto-immunes
Alimentation
Inflammation
Examens médicaux
Prévention
Traitements
5
Immunosuppresseurs
Corticostéroïdes
Traitement
Maladies auto-immunes
Thérapies biologiques
Autoanticorps
Mode de vie
Gestion des symptômes
Complications
5
Complications
Dommages aux organes
Maladies cardiovasculaires
Autoanticorps
Complications
Gestion des symptômes
Infections
Maladies auto-immunes
Complications neurologiques
Troubles cognitifs
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Facteurs environnementaux
Infections
Tabagisme
Maladies auto-immunes
Déséquilibres hormonaux
Autoanticorps
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Autoanticorps : Questions médicales les plus fréquentes",
"headline": "Autoanticorps : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Autoanticorps : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Autoanticorps"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anticorps",
"url": "https://questionsmedicales.fr/mesh/D000906",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps",
"code": {
"@type": "MedicalCode",
"code": "D000906",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-protéines citrullinées",
"alternateName": "Anti-Citrullinated Protein Antibodies",
"url": "https://questionsmedicales.fr/mesh/D000075422",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-protéines citrullinées",
"code": {
"@type": "MedicalCode",
"code": "D000075422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.095"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antinucléaires",
"alternateName": "Antibodies, Antinuclear",
"url": "https://questionsmedicales.fr/mesh/D000974",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antinucléaires",
"code": {
"@type": "MedicalCode",
"code": "D000974",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.204"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anticorps antiphospholipides",
"alternateName": "Antibodies, Antiphospholipid",
"url": "https://questionsmedicales.fr/mesh/D017152",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps antiphospholipides",
"code": {
"@type": "MedicalCode",
"code": "D017152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anticardiolipines",
"alternateName": "Antibodies, Anticardiolipin",
"url": "https://questionsmedicales.fr/mesh/D017153",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anticardiolipines",
"code": {
"@type": "MedicalCode",
"code": "D017153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.210.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Facteur néphritique C3",
"alternateName": "Complement C3 Nephritic Factor",
"url": "https://questionsmedicales.fr/mesh/D003178",
"about": {
"@type": "MedicalCondition",
"name": "Facteur néphritique C3",
"code": {
"@type": "MedicalCode",
"code": "D003178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoconglutinines",
"alternateName": "Immunoconglutinins",
"url": "https://questionsmedicales.fr/mesh/D037561",
"about": {
"@type": "MedicalCondition",
"name": "Immunoconglutinines",
"code": {
"@type": "MedicalCode",
"code": "D037561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Immunoglobulines thyréostimulantes",
"alternateName": "Immunoglobulins, Thyroid-Stimulating",
"url": "https://questionsmedicales.fr/mesh/D018828",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines thyréostimulantes",
"code": {
"@type": "MedicalCode",
"code": "D018828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.480"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur rhumatoïde",
"alternateName": "Rheumatoid Factor",
"url": "https://questionsmedicales.fr/mesh/D012217",
"about": {
"@type": "MedicalCondition",
"name": "Facteur rhumatoïde",
"code": {
"@type": "MedicalCode",
"code": "D012217",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114.323.732"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Autoanticorps",
"alternateName": "Autoantibodies",
"code": {
"@type": "MedicalCode",
"code": "D001323",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Iago Pinal-Fernandez",
"url": "https://questionsmedicales.fr/author/Iago%20Pinal-Fernandez",
"affiliation": {
"@type": "Organization",
"name": "Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA andrew.mammen@nih.gov iago.pinalfernandez@nih.gov."
}
},
{
"@type": "Person",
"name": "Katherine Pak",
"url": "https://questionsmedicales.fr/author/Katherine%20Pak",
"affiliation": {
"@type": "Organization",
"name": "Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA."
}
},
{
"@type": "Person",
"name": "Sarah L Tansley",
"url": "https://questionsmedicales.fr/author/Sarah%20L%20Tansley",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy and pharmacology, University of Bath, Bath, UK."
}
},
{
"@type": "Person",
"name": "Gunnar Houen",
"url": "https://questionsmedicales.fr/author/Gunnar%20Houen",
"affiliation": {
"@type": "Organization",
"name": "Department of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark. gh@ssi.dk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Incidental finding of intramural splenic heterotopy in the colon mimicking subepithelial neoplasm: a case report.",
"datePublished": "2024-09-19",
"url": "https://questionsmedicales.fr/article/39294715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-024-04766-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Difference in the prevalence of advanced colon adenoma between patients with gastric neoplasm and healthy people: A STROBE-compliant study.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35623070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MD.0000000000029308"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbiome in Colonic Carcinogenesis.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37358517",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cphy.c210052"
}
},
{
"@type": "ScholarlyArticle",
"name": "Compound Capecitabine Colon-Targeted Microparticle Prepared by Coaxial Electrospray for Treatment of Colon Tumors.",
"datePublished": "2022-09-03",
"url": "https://questionsmedicales.fr/article/36080457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27175690"
}
},
{
"@type": "ScholarlyArticle",
"name": "MLH1 Gene Expression in Peripheral Blood in Colon Cancer Patients and Their Association with Colon Cancer.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39400169",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/66387"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
},
{
"@type": "ListItem",
"position": 8,
"name": "Autoanticorps",
"item": "https://questionsmedicales.fr/mesh/D001323"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Autoanticorps - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Autoanticorps",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Autoanticorps",
"description": "Comment détecte-t-on les autoanticorps ?\nQuels tests sont utilisés pour les autoanticorps ?\nLes autoanticorps sont-ils toujours présents dans les maladies auto-immunes ?\nPeut-on avoir des autoanticorps sans symptômes ?\nQuel rôle jouent les autoanticorps dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Autoanticorps",
"description": "Quels symptômes sont associés aux autoanticorps ?\nLes autoanticorps causent-ils des douleurs articulaires ?\nPeut-on avoir des symptômes neurologiques avec des autoanticorps ?\nLes éruptions cutanées sont-elles liées aux autoanticorps ?\nLes autoanticorps peuvent-ils affecter les organes internes ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Autoanticorps",
"description": "Peut-on prévenir la production d'autoanticorps ?\nLes vaccinations influencent-elles les autoanticorps ?\nLe stress peut-il augmenter les autoanticorps ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes examens médicaux réguliers aident-ils à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Autoanticorps",
"description": "Comment traite-t-on les maladies liées aux autoanticorps ?\nLes traitements sont-ils les mêmes pour tous les autoanticorps ?\nLes thérapies biologiques sont-elles efficaces contre les autoanticorps ?\nPeut-on guérir des maladies causées par des autoanticorps ?\nLes changements de mode de vie aident-ils à gérer les autoanticorps ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Autoanticorps",
"description": "Quelles complications peuvent survenir avec des autoanticorps ?\nLes autoanticorps peuvent-ils causer des maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?\nLes infections sont-elles plus fréquentes avec des autoanticorps ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Autoanticorps",
"description": "Quels sont les facteurs de risque pour les autoanticorps ?\nL'âge influence-t-il la production d'autoanticorps ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLes déséquilibres hormonaux affectent-ils les autoanticorps ?",
"url": "https://questionsmedicales.fr/mesh/D001323?mesh_terms=Colonic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les autoanticorps ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les autoanticorps sont détectés par des tests sanguins spécifiques, comme l'ELISA."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les autoanticorps ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests courants incluent le dosage des anticorps antinucléaires (ANA) et des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Les autoanticorps sont-ils toujours présents dans les maladies auto-immunes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur présence peut varier selon la maladie et le stade de la maladie."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des autoanticorps sans symptômes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des autoanticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les autoanticorps dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à confirmer le diagnostic de maladies auto-immunes et à évaluer leur activité."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux autoanticorps ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais peuvent inclure fatigue, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les autoanticorps causent-ils des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des douleurs articulaires dans des maladies comme la polyarthrite rhumatoïde."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes neurologiques avec des autoanticorps ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains autoanticorps sont associés à des troubles neurologiques comme la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles liées aux autoanticorps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées peuvent survenir dans des maladies comme le lupus érythémateux systémique."
}
},
{
"@type": "Question",
"name": "Les autoanticorps peuvent-ils affecter les organes internes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent endommager des organes comme les reins, le cœur ou les poumons dans certaines maladies."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la production d'autoanticorps ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les autoanticorps ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent déclencher des autoanticorps, mais les bénéfices l'emportent souvent."
}
},
{
"@type": "Question",
"name": "Le stress peut-il augmenter les autoanticorps ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les maladies auto-immunes et augmenter les autoanticorps."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et en oméga-3 peut aider à réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les examens médicaux réguliers aident-ils à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on les maladies liées aux autoanticorps ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des immunosuppresseurs, des anti-inflammatoires et des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les autoanticorps ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le traitement dépend du type de maladie auto-immune et des autoanticorps présents."
}
},
{
"@type": "Question",
"name": "Les thérapies biologiques sont-elles efficaces contre les autoanticorps ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies biologiques ciblent spécifiquement les mécanismes des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on guérir des maladies causées par des autoanticorps ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de guérison, mais les traitements peuvent contrôler les symptômes et la progression."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils à gérer les autoanticorps ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée, l'exercice et la gestion du stress peuvent aider à la gestion."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des autoanticorps ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des dommages aux organes, des infections et des troubles auto-immuns."
}
},
{
"@type": "Question",
"name": "Les autoanticorps peuvent-ils causer des maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains autoanticorps sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent causer des dommages permanents."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles plus fréquentes avec des autoanticorps ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des maladies auto-immunes ont un risque accru d'infections."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, comme des troubles cognitifs ou des crises."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les autoanticorps ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin et certaines infections."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la production d'autoanticorps ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la production d'autoanticorps augmente souvent avec l'âge, surtout chez les femmes."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines ou à des infections peut déclencher la production d'autoanticorps."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de maladies auto-immunes et d'autoanticorps."
}
},
{
"@type": "Question",
"name": "Les déséquilibres hormonaux affectent-ils les autoanticorps ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les déséquilibres hormonaux, notamment chez les femmes, peuvent influencer la production d'autoanticorps."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/02/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
4 publications dans cette catégorie
Affiliations :
Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA andrew.mammen@nih.gov iago.pinalfernandez@nih.gov.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publications dans "Autoanticorps" :
4 publications dans cette catégorie
Affiliations :
Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Publications dans "Autoanticorps" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy and pharmacology, University of Bath, Bath, UK.
Publications dans "Autoanticorps" :
3 publications dans cette catégorie
Affiliations :
Department of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark. gh@ssi.dk.
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark. gh@ssi.dk.
Publications dans "Autoanticorps" :
3 publications dans cette catégorie
Affiliations :
Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publications dans "Autoanticorps" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publications dans "Autoanticorps" :
3 publications dans cette catégorie
Affiliations :
Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Department of Dermatology, International University of Health and Welfare Narita Hospital, Chiba 286-8520, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tokyo 100-0013, Japan.
ProteoBridge Corporation, Tokyo 135-0064, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
ProteoBridge Corporation, Tokyo 135-0064, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
ProteoBridge Corporation, Tokyo 135-0064, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tokyo 100-0013, Japan.
ProteoBridge Corporation, Tokyo 135-0064, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, Japan.
Publications dans "Autoanticorps" :
The aim of this case report is describe an unprecedented case with histological and immunohistochemical diagnosis of splenic heterotopy in the colon using material obtained by endoscopic ultrasound-gu...
Splenic heterotopia is a benign condition characterized by the implantation of splenic tissue in areas distant from its usual anatomical site, such as the peritoneum, omentum, mesentery, liver, pancre...
A 35-year-old white male patient who was healthy, with no history of trauma or splenectomy, but had a family history of colorectal neoplasia underwent colonoscopy for screening. The examination reveal...
This is the first report of a primary intramural colic splenosis case with histological and immunohistochemical diagnosis of splenic heterotopia in the colon, using material obtained by endoscopic ult...
We compared the prevalence of adenoma and cancerous colon polyps in patients undergoing endoscopic removal or gastric surgery for gastric adenoma or gastric cancer and in healthy individuals.The medic...
Microbiomes include bacteria, viruses, fungi, and other microbes. The microbiome modulates numerous aspects of host physiology and is critical in the pathophysiology of diseases, including colon cance...
To improve the antitumor effect of combined capecitabine (CAP) and osimertinib (OSI) therapy and quickly and efficiently reduce tumor volumes for preoperative chemotherapy, we designed a compound CAP ...
MutL homolog 1 (MLH1) is a component of the heterodimeric complex MutLα that detects and fixes base-base mismatches and insertion/deletion loops caused by nucleotide misincorporation. In the absence o...
Schwannomas are nerve sheath tumours that can be found throughout the body along peripheral nerves. Primary schwannomas of the colon are very rare. They are usually benign and their surgical resection...
Despite advances in endoscopic techniques for management of benign colonic neoplasms, a rise in rates of surgical treatment has been reported. We used a nationally representative cohort to characteriz...
All patients undergoing elective partial colectomy for benign or malignant colonic neoplasms were identified using the 2012-2019 National Inpatient Sample. Those presenting with inflammatory bowel dis...
Of 569,280 colectomy procedures included for analysis, 153,435 (27.0%) were performed for benign lesions. The proportion of Benign operations decreased from 28.6% in 2012 to 23.7% in 2019 (P for trend...
The present national study identifies a decrease in colectomy for benign polyps from 2012-2019. Future investigations should identify patients who would most benefit from surgical resection and addres...
A man in his 60s presented to our emergency department with severe peripheral pitting oedema, weight gain, dyspnoea and diarrhoea. Blood tests showed a hypoalbuminaemia of 15 g/L. A suspicion of prote...
To evaluate DNA ploidy and S-phase fraction (SPF) in non-Lynch colonic adenocarcinoma, ulcerative colitis (UC), Crohn disease (CD) which are known as risk factors, and colitis. We correlated ploidy an...
All studied adenocarcinomas have intact mismatch repair genes as proved by immunohistochemistry. All were assessed for ploidy by automated image-based DNA cytometry and histograms were drawn. Immunost...
there is significant difference in DNA ploidy between groups; 77.5% and 17.5% of aneuploid cases are adenocarcinoma and UC. Groups are compared in terms of 2C, 4C, above 4C DNA content and SPF and sig...
Based on significant difference in ploidy between adenocarcinoma and UC and between SPF and ploidy, assessment of ploidy by DNA cytometry for UC and other colitis could therefore predict impending mal...
Colonic malakoplakia is an uncommon granulomatous development of cells resulting from the impaired capacity of the mononuclear cells to eliminate the phagocytosed bacteria, and in rare cases it can al...